Insempra, an innovative biotechnology company, has completed a $20 million Series A financing round. This investment follows an initial $15 million seed round in 2021 and marks a significant milestone in accelerating Insempra's efforts to revolutionize the beauty and food industries with its sustainable, bio-based ingredients.
The Series A round saw participation from both existing and new investors, highlighting widespread recognition of Insempra's potential to transform industrial manufacturing. Key contributors include EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, Acequia Capital, Henkel dx Ventures, Bayern Kapital, and Alante Capital. This funding will support the expansion of Insempra's technology platform, which develops high-performance, sustainable ingredients for a variety of industries.
Insempra's mission is to address pressing environmental concerns by leveraging advanced biotechnological methods. The company is pioneering the production of lipids for cosmetic and food applications and is developing bio-based alternatives to everyday materials like polymers and textiles. This approach aims to reduce dependency on traditional chemical industrial processes, thereby lessening environmental impact. Jens Klein, the founder and CEO of Insempra, emphasizes that the company is inspired to create a better future in collaboration with nature. This market-first approach allows Insempra to develop superior ingredients that meet evolving consumer demands and regulatory standards.
Insempra's technology platform supports the creation of new natural molecules for functional ingredients such as antioxidants, preservatives, flavors, and fragrances. These developments are crucial as industries like beauty, personal care, food, and fashion face mounting pressure to shift to sustainable alternatives due to consumer demand and regulatory changes. The company's ability to produce these ingredients with atomic precision ensures that they can be rapidly manufactured at scale, offering better solutions compared to agriculturally and petrochemically sourced materials.
Jens Klein, who previously led AMSilk GmbH, brings extensive experience in developing biologically superior ingredients. Under his leadership, Insempra is committed to creating sustainable materials that meet evolving consumer demands and regulatory standards.
"We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platforms," said Klein. "Working in collaboration with nature, we will continue to expand our capacity to develop intrinsically sustainable materials that are superior in quality and will reduce our dependency on chemical industrialization processes."
EQT Ventures' Ted Persson added, "Insempra has both the team and the technology to drive a revolution in industrial manufacturing and gain rapid market traction for its products. New technology platforms such as Insempra’s have the potential to dramatically change the manufacturing processes of multiple multibillion-dollar industries, developing customized ingredients to fit market needs."
Insempra's vision aligns with the increasing imperative for businesses to adopt environmentally responsible practices. The company's technology platform supports the creation of new natural molecules for use in functional ingredients like antioxidants, preservatives, flavors, and fragrances. This innovation is crucial as the beauty, personal care, food, and fashion industries face mounting pressure to shift to sustainable alternatives due to consumer demand and regulatory changes.
With this substantial financial backing, Insempra is well-positioned to lead a transformation in how industrial products are manufactured, promoting a more sustainable future across various sectors.
Comments